global Downstream Processing Market 2031
PORTLAND, OREGON, UNITED STATES, July 14, 2023/EINPresswire.com/ — According to the report published by Allied Market Research, the global Downstream Processing Market was estimated at $21.8 billion in 2020 and is expected to hit $92.0 billion by 2030, registering a CAGR of 13.5% from 2021 to 2030. The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.
Key Takeaways:
Definition: Downstream processing refers to the purification and recovery of bio-based products, such as biopharmaceuticals, from a biological source or fermentation broth. It involves a series of steps, including separation, purification, concentration, and formulation, to obtain the desired final product.
Growing Biopharmaceutical Industry: The downstream processing market is experiencing significant growth due to the expanding biopharmaceutical industry. Biopharmaceuticals, including antibodies, vaccines, hormones, and enzymes, are increasingly being used for the treatment of various diseases, driving the demand for downstream processing technologies.
Increasing R&D Activities: Advancements in biotechnology and the rising focus on developing innovative bio-based products have led to increased research and development activities. This, in turn, has fueled the demand for downstream processing technologies to purify and extract valuable products.
Technological Advancements: The downstream processing market has witnessed notable technological advancements, such as the development of automated systems, single-use technologies, and continuous processing methods. These advancements have improved process efficiency, reduced production costs, and minimized contamination risks.
Rising Adoption of Single-Use Technologies: Single-use technologies are gaining popularity in downstream processing due to their advantages, such as reduced cross-contamination risks, faster turnaround times, and lower capital investments. The adoption of single-use systems, such as disposable filters and chromatography columns, has increased in biopharmaceutical manufacturing processes.
Stringent Regulations: Regulatory bodies, such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have implemented stringent guidelines for the production and purification of biopharmaceuticals. Compliance with these regulations is essential for market players to ensure product quality, safety, and efficacy.
Geographical Considerations: North America and Europe have traditionally been the dominant regions in the downstream processing market, attributed to the presence of well-established biopharmaceutical companies, advanced infrastructure, and supportive regulatory frameworks. However, the market is witnessing significant growth in emerging economies, particularly in the Asia-Pacific region, due to increasing investments in the biopharmaceutical sector.
Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/2862
Market Drivers:
Expansion of the Biopharmaceutical Industry: The biopharmaceutical sector is experiencing significant growth due to the increasing prevalence of chronic diseases, advancements in biotechnology, and a shift toward personalized medicine. This growth has led to a higher demand for downstream processing technologies to purify and isolate bio-based products, such as antibodies, vaccines, and recombinant proteins.
Growing Biologics Market: Biologics, including monoclonal antibodies, therapeutic proteins, and vaccines, have gained prominence in the pharmaceutical industry. The rising demand for biologics, driven by their effectiveness and specificity in treating various diseases, has resulted in increased investments in downstream processing technologies to meet production requirements.
Market Segmentation:
Product Type:
a. Chromatography Systems: Includes liquid chromatography, affinity chromatography, ion exchange chromatography, and other chromatography systems.
b. Filters: Comprises microfiltration, ultrafiltration, nanofiltration, and other filtration systems.
c. Centrifuges: Includes disc centrifuges, sedimentation centrifuges, and other types of centrifuges.
d. Evaporators: Includes single-effect evaporators, multi-effect evaporators, and other types of evaporators.
e. Dryers: Comprises freeze dryers, spray dryers, and other types of dryers.
f. Others: Includes mixers, homogenizers, and other downstream processing equipment.
Application:
a. Monoclonal Antibody Production
b. Vaccine Production
c. Recombinant Protein Production
d. Insulin Production
e. Enzyme Production
f. Others
End User:
a. Biopharmaceutical Companies
b. Contract Manufacturing Organizations (CMOs)
c. Research Institutes and Academic Centers
d. Others
Process Scale:
a. Large-Scale Downstream Processing: Primarily used for commercial production, involving large volumes of biopharmaceuticals.
b. Medium-Scale Downstream Processing: Used for scale-up studies, process development, and clinical trial production.
c. Small-Scale Downstream Processing: Utilized in research and development, lab-scale production, and pilot plant operations.
Geography:
a. North America
b. Europe
c. Asia-Pacific
d. Latin America
e. Middle East and Africa
Request for Customization – https://www.alliedmarketresearch.com/request-for-customization/2862
Regional Growth Dynamics:
The market across North America held the lion’s share in 2020, garnering around two-fifths of the global market. The Asia-Pacific region, on the other hand, is expected to cite the fastest CAGR of 14.6% by the end of 2030. The other provinces studied in the report include Europe and LAMEA.
Competitive Landscape
Danaher Corporation, Repligen Corporation, Thermo Fisher Scientific Inc., Merck & Co., Inc., Boehringer Ingelheim, Lonza Group AG, Eppendorf AG, 3M Company, Finesse Solutions, Inc., and Sartorius Stedim Biotech S.A.
Buy this Premium Research Report: https://www.alliedmarketresearch.com/purchase-enquiry/2862
VALUE PROPOSITIONS RELATED TO THE REPORT:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Browse more latest healthcare reports:
Analgesics Market
Medical/Diagnostic Imaging Market
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
David Correa
Allied Analytics LLP
1 800-792-5285
email us here
